Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Opin Investig Drugs. 2002 Sep;3(9):1334-41.Links

Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo.

University College London, Institute of Urology and Nephrology, Division of Applied Physiology, 48 Riding House Street, London, W1W 7EY, UK. naflor40@hotmail.com

Pitavastatin (nisvastatin) is an HMG CoA reductase inhibitor being developed jointly by Nissan, Kowa Kogyo, Novartis and Sankyo for the potential treatment of atherosclerosis and hyperlipidemia.

PMID: 12498010 [PubMed - indexed for MEDLINE]